Key facts
- This page summarizes Jr. Robert E. Funck's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 23 Feb 2022, 19:12.
Jr. Robert E. Funck - 18 Feb 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Signature
- /s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
- Issuer symbol
- ABT
- Transactions as of
- 18 Feb 2022
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 23 Feb 2022, 19:12:04 UTC
- Next filing
- 02 Mar 2022
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Jr. Robert E. Funck filed Form 4 for ABBOTT LABORATORIES (ABT) on 23 Feb 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported transactions
ABT
transaction
Common shares without par value
Award
- Transaction value
- $0
- Shares
- +28,682
- Change %
- +15%
- Price
- $0.000000
- Shares after
- 217,332
- Date
- 18 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 18 Feb 2022
- Ownership
- By Trust
- Footnotes
- F2
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 18 Feb 2022
- Ownership
- By Trust
- Footnotes
- F2
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,085
- Date
- 18 Feb 2022
- Ownership
- Profit Sharing Trust
- Footnotes
- F3
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500
- Date
- 18 Feb 2022
- Ownership
- By Daughter
- Footnotes
- F4
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
ABT
transaction
Derivative
Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +133,670
- Change %
- Price
- $0.000000
- Shares after
- 133,670
- Date
- 18 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 133,670
- Exercise price
- $117.58
- Footnotes
- F5
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. |
| F2 | Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust. |
| F3 | Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022. |
| F4 | The reporting person disclaims beneficial ownership of all securities held by his daughter. |
| F5 | Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 44,556 on February 18, 2023, 44,557 on February 18, 2024, and 44,557 on February 18, 2025. |